Literature DB >> 23380872

Organocatalytic multicomponent reaction for the acquisition of a selective inhibitor of mPTPB, a virulence factor of tuberculosis.

Rongjun He1, Li-Fan Zeng, Yantao He, Li Wu, Andrea Michelle Gunawan, Zhong-Yin Zhang.   

Abstract

Mycobacterium protein tyrosine phosphatase B (mPTPB) is essential for the survival and persistence of Mycobacterium in the host. Thus small molecule inhibitors of mPTPB are potential anti-TB agents. We developed an efficient organocatalytic multicomponent reaction (MCR) between pyrrole, formaldehyde and aniline, affording a potent and selective mPTPB inhibitor with an IC(50) value of 1.5 μM and >50-fold specificity. Our studies provide a successful example of using organocatalysis as a discovery tool for the acquisition of PTP inhibitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380872      PMCID: PMC3586706          DOI: 10.1039/c3cc38961h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  26 in total

Review 1.  Global tuberculosis drug development pipeline: the need and the reality.

Authors:  Zhenkun Ma; Christian Lienhardt; Helen McIlleron; Andrew J Nunn; Xiexiu Wang
Journal:  Lancet       Date:  2010-05-18       Impact factor: 79.321

2.  Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis.

Authors:  Andrea Nören-Müller; Ivan Reis-Corrêa; Heino Prinz; Claudia Rosenbaum; Krishna Saxena; Harald J Schwalbe; Dietmar Vestweber; Guiseppe Cagna; Stefan Schunk; Oliver Schwarz; Hajo Schiewe; Herbert Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-29       Impact factor: 11.205

3.  Fragment-based substrate activity screening method for the identification of potent inhibitors of the Mycobacterium tuberculosis phosphatase PtpB.

Authors:  Matthew B Soellner; Katherine A Rawls; Christoph Grundner; Tom Alber; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2007-07-18       Impact factor: 15.419

4.  Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.

Authors:  Andrew P Combs
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

5.  High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.

Authors:  Lay Pheng Tan; Hao Wu; Peng-Yu Yang; Karunakaran A Kalesh; Xiaohua Zhang; Mingyu Hu; Rajavel Srinivasan; Shao Q Yao
Journal:  Org Lett       Date:  2009-11-19       Impact factor: 6.005

6.  Direct asymmetric three-component organocatalytic anti-selective Mannich reactions in a purely aqueous system.

Authors:  Lili Cheng; Xiaoyu Wu; Yixin Lu
Journal:  Org Biomol Chem       Date:  2007-02-14       Impact factor: 3.876

7.  Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors.

Authors:  Yantao He; Li-Fan Zeng; Zhi-Hong Yu; Rongjun He; Sijiu Liu; Zhong-Yin Zhang
Journal:  Bioorg Med Chem       Date:  2011-11-09       Impact factor: 3.641

Review 8.  Inhibitors of protein tyrosine phosphatases: next-generation drugs?

Authors:  Laurent Bialy; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2005-06-20       Impact factor: 15.336

9.  Diastereoselective HOTf-catalyzed three-component one-pot 1,3-dipolar cycloaddition of alpha-diazo ester, nitrosobenzene and electron-deficient alkene.

Authors:  Zhen-Jiang Xu; Di Zhu; Xiaofei Zeng; Fei Wang; Bin Tan; Yuxuan Hou; Yunbo Lv; Guofu Zhong
Journal:  Chem Commun (Camb)       Date:  2010-02-01       Impact factor: 6.222

10.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.

Authors:  Y A Puius; Y Zhao; M Sullivan; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

View more
  5 in total

Review 1.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

2.  One-pot sequential multicomponent reaction between in situ generated aldimines and succinaldehyde: facile synthesis of substituted pyrrole-3-carbaldehydes and applications towards medicinally important fused heterocycles.

Authors:  Anoop Singh; Nisar A Mir; Sachin Choudhary; Deepika Singh; Preetika Sharma; Rajni Kant; Indresh Kumar
Journal:  RSC Adv       Date:  2018-04-24       Impact factor: 4.036

3.  Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.

Authors:  Xin Hu; Jie Wang; Yingjiao Ju; Xiuli Zhang; Wushou'er Qimanguli; Cuidan Li; Liya Yue; Bahetibieke Tuohetaerbaike; Ying Li; Hao Wen; Wenbao Zhang; Changbin Chen; Yefeng Yang; Jing Wang; Fei Chen
Journal:  BMC Infect Dis       Date:  2022-08-25       Impact factor: 3.667

4.  An organocatalytic route to 2-heteroarylmethylene decorated N-arylpyrroles.

Authors:  Alexandre Jean; Jérôme Blanchet; Jacques Rouden; Jacques Maddaluno; Michaël De Paolis
Journal:  Beilstein J Org Chem       Date:  2013-07-24       Impact factor: 2.883

5.  Characterization of Rv0888, a Novel Extracellular Nuclease from Mycobacterium tuberculosis.

Authors:  Guanghui Dang; Jun Cao; Yingying Cui; Ningning Song; Liping Chen; Hai Pang; Siguo Liu
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.